A preparation method of tebuconazole and antibacterial composition thereof

By using CH3ONa and KOH catalysts, the preparation purity and yield of tetrazolidol were improved, and combined with wolf toxin, a highly efficient antibacterial composition was prepared, which solved the low purity and yield of tetrazolidol in the prior art. The problem is that it expands the sterilization spectrum and reduces environmental pollution and drug resistance.

CN117263874BActive Publication Date: 2024-11-29CHENGWU CHENHUI ENVIRONMENTAL PROTECTION TECH CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202311106040.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-08-30
Publication Date
2024-11-29
Estimated Expiration
2043-08-30

AI Technical Summary

Technical Problem

In the prior art, the purity and yield of the catalyst in the preparation method of pivalazole alcohol are low, and there is no report that pivalazole alcohol and wolf toxin are used as antibacterial compositions, which cannot effectively improve the prevention and treatment effect and expand the prevention and treatment spectrum.

Method used

Using CH3ONa and KOH as catalysts, the reaction of epoxy of piperazole and 1,2,4-triazole at 95-105°C was carried out, and combined with n-butanol as solvents were combined to obtain piperazole alcohol and was purified with wolves. Toxins are formulated into antibacterial compositions in specific proportions, including additives such as sodium lauryl sulfate, dodecylbenzenesulfonic acid, etc., and suspension agents are prepared by phacoemulsification and sanding.

Benefits of technology

The yield and purity of tetrazoleol was improved, and the yield of more than 95% and purity of more than 98.5% was achieved. The combination of tetrazoleol and wolf toxin was used to expand the bactericidal spectrum, enhance the antibacterial effect, and reduce the The amount of pesticides is used to reduce environmental pollution and delay the generation of pathogenic bacteria resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004422124610000071
    Figure BDA0004422124610000071
  • Figure BDA0004422124610000081
    Figure BDA0004422124610000081
Patent Text Reader

Abstract

The invention discloses a method for preparing tebuconazole and an antibacterial composition thereof, and belongs to the technical field of pesticides. The method for preparing the tebuconazole comprises the following steps: using tebuconazole epoxide and 1,2,4-triazole as reaction base materials, using CH3ONa and KOH as catalysts, using n-butanol as an organic solvent, reacting for 11-12 hours at a temperature of 95-105°C, and purifying to obtain tebuconazole; the active ingredients of the antibacterial composition are tebuconazole and wolfsbane, and the mass ratio of the tebuconazole to wolfsbane is (10-20): 1. The preparation process of the tebuconazole of the invention adopts CH3ONa and KOH as catalysts, and adopts a one-pot method, the process is simple, and the yield of tebuconazole reaches more than 95%, and the purity is more than 98.5%; the invention selects tebuconazole and wolfsbane for compounding, wolfsbane and tebuconazole have different action mechanisms, and the two are compounded to expand the bactericidal spectrum, improve the prevention and control effect, and also help to delay the generation of drug resistance of pathogens.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of pesticides, and in particular to a preparation method of tebuconazole and an antibacterial composition thereof. Background Art

[0002] Tebuconazole is a highly effective, broad-spectrum, systemic triazole fungicide pesticide with three functions: protection, treatment, and eradication. It has a broad fungicide spectrum and a long lasting effect. Tebuconazole is used as a seed treatment agent and foliar spray worldwide. It has a broad fungicide spectrum, high activity, and a long lasting effect. Tebuconazole is a highly effective fungicide used for seed treatment or foliar spraying of important economic crops. It can be quickly absorbed by the growing part of the plant and mainly transmitted to the top. It not only has fungicide activity, but also can promote plant growth, make the root system well-developed, the leaves dark green, and the plants strong, thereby increasing yield. It can effectively prevent and control various rusts, powdery mildew, web spot, root rot, fusarium head blight, smut, and seed-borne ring spot of cereal crops.

[0003] In the prior art, p-chloroformaldehyde is often used as a raw material, and tebuconazole epoxide is obtained through aldol condensation, catalytic hydrogenation, and epoxidation, and then tebuconazole is obtained through a ring-opening reaction with 1,2,4-triazole. In the ring-opening reaction of tebuconazole epoxide and 1,2,4-triazole, a single alkaline substance such as NaOH or organic ammonium is often selected as a catalyst. The alkaline environment created by the catalyst is conducive to the ring opening of the epoxide and promotes the formation of tebuconazole. When NaOH is selected as a catalyst, the purity of tebuconazole is only 96.1% and the yield is 85.5%. When organic ammonium is used as a catalyst, the purity of tebuconazole is only 75.7% and the yield is 70.3%. Since the purity and yield of tebuconazole prepared by the catalyst for ring opening of tebuconazole epoxide in the prior art are both low, a preparation method of tebuconazole is needed to improve the yield and purity of tebuconazole.

[0004] Wolfsbane is a chemical component extracted from the root of Wolfsbane, a plant of the Thymelaeaceae family. As a plant-derived chemical component, it has the advantages of low toxicity and safety for crops. Studies have shown that wolfsbane has a good control effect on pests such as cabbage worms, diamondback moths, aphids, cotton bollworms, vermilion spider mites, and oxalis spider mites. It has a certain antibacterial effect on a variety of common plant pathogens such as potato silk core, watermelon vine blight, wolfberry anthracnose, and rapeseed sclerotia, and has good development potential. Antibacterial compositions play an important role in improving prevention efficacy, expanding the control spectrum, reducing dosage, and delaying the development of resistance. At present, there is no report on the combined use of tebuconazole and wolfsbane as an antibacterial composition. Summary of the invention

[0005] In view of the above prior art, the object of the present invention is to provide a method for preparing tebuconazole and an antibacterial composition thereof.

[0006] To achieve the above object, the present invention adopts the following technical solution:

[0007] The first aspect of the present invention provides a method for preparing tebuconazole, comprising the following steps: using tebuconazole epoxide and 1,2,4-triazole as reaction substrates, CH3ONa and KOH as catalysts, and n-butanol as an organic solvent, reacting for 11-12 hours at a temperature of 95-105°C, and purifying to obtain tebuconazole.

[0008] Preferably, the molar ratio of tebuconazole epoxide, 1,2,4-triazole, CH3ONa and KOH is 5:6:1:3.

[0009] Preferably, the mass ratio of the tebuconazole epoxide to n-butanol is 1:3.

[0010] Preferably, the purification method is: after the reaction is completed, the reaction solution is subjected to reduced pressure distillation to recover the solvent, the residue is extracted with toluene, washed with water, and the obtained organic phase is cooled, filtered, and dried to obtain tebuconazole.

[0011] The second aspect of the present invention provides an antibacterial composition containing tebuconazole, wherein the active ingredients of the antibacterial composition are tebuconazole and wolfsbane, and the mass ratio of tebuconazole to wolfsbane is (10-20):1.

[0012] Preferably, the mass ratio of tebuconazole to wolfberry is 15:1.

[0013] Preferably, the tebuconazole and wolfsbane account for 10% to 50% of the mass of the antibacterial composition.

[0014] Preferably, the antibacterial composition further comprises an auxiliary agent accounting for 10% to 15% of the mass of the antibacterial composition, and the auxiliary agent is compounded from the following raw materials in parts by mass: 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, and 5 parts of ethylene glycol.

[0015] The third aspect of the present invention provides a method for preparing the above-mentioned antibacterial composition, comprising the following steps:

[0016] (1) adding tebuconazole, wolfberry toxin, sodium lauryl sulfate, dodecylbenzenesulfonic acid, n-octanol, xanthan gum, benzoic acid, and ethylene glycol to deionized water in sequence, and uniformly emulsifying by ultrasonic emulsification to obtain a mixture;

[0017] (2) The mixed material is sand-milled and homogenized to obtain a suspension which is the antibacterial composition.

[0018] Preferably, in step (1), the ultrasonic emulsification time is 20-30 minutes.

[0019] Preferably, in step (2), the sand grinding time is 2-4 hours and the homogenization time is 30-40 minutes.

[0020] The fourth aspect of the present invention provides the effect of the above-mentioned antibacterial composition in preventing and controlling crop diseases.

[0021] Furthermore, the crop disease is wheat root rot, wheat fusarium head blight, wheat take-all disease or kiwi fruit canker.

[0022] Tebuconazole is a triazole fungicide and an ergosterol biosynthesis inhibitor. After spraying, the agent can be quickly absorbed by the plant and mainly transferred to the top. The agent enters the body of the pathogen and inhibits the demethylation of ergosterol on the cell membrane of the pathogen, making it impossible for the pathogen to form a cell membrane, thereby inhibiting the normal growth of the pathogen.

[0023] Wolfsbane is a flavonoid plant-derived insecticide, and is an extract of the rhizome of Wolfsbane Chamaejasme, a plant of the Thymelaeaceae family, which grows in northwest Sichuan and other places in my country. It has a strong effect on a variety of plant pathogens, and has contact and stomach poisoning effects on a variety of insect pests and mites, with little environmental pollution and no adverse effects on crops. The present invention combines wolfsbane with tebuconazole, which has different mechanisms of action, and the two are compounded to expand the bactericidal spectrum, improve the control effect, and also help delay the generation of drug resistance in pathogens.

[0024] Beneficial effects of the present invention:

[0025] 1. The preparation process of tebuconazole of the present invention adopts CH3ONa and KOH as catalysts and adopts a one-pot method, the process is simple, and the yield of tebuconazole reaches more than 95% and the purity is more than 98.5%.

[0026] 2. The present invention selects wolfsbane and tebuconazole for compounding, which can play a synergistic role, enhance the antibacterial effect of the antibacterial composition, and expand the bactericidal spectrum.

[0027] 3. The antibacterial composition of the present invention reduces the amount of pesticides used, thereby reducing costs and reducing environmental pollution, has good safety, and is also conducive to delaying the development of drug resistance in pathogens. DETAILED DESCRIPTION

[0028] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.

[0029] In order to enable those skilled in the art to more clearly understand the technical solution of the present application, the technical solution of the present application will be described in detail below in conjunction with specific embodiments.

[0030] The test materials used in the examples of the present invention are all conventional test materials in the art and can be purchased through commercial channels.

[0031] Tebuconazole epoxide used in the following examples and comparative examples of the present invention was purchased from Guangzhou Kafen Biotechnology Co., Ltd. with a purity of 99%.

[0032] The 1,2,4-triazole used in the following examples and comparative examples of the present invention was purchased from Aladdin Reagent (Shanghai) Co., Ltd. with a purity of 99%.

[0033] The wolfsbane used in the following examples and comparative examples of the present invention was purchased from Shanghai Yuanye Biotechnology Co., Ltd. with a product number of B52686-5mg.

[0034] The strains used in the experiment: Bipolaris sorokiniana was purchased from the China General Microbiological Culture Collection with a collection number of CGMCC 3.17679; Fusarium graminearum was purchased from the China Center for Type Culture Collection with a collection number of CCTCC KF 2008444; Gaeumannomyces graminis was purchased from the China Center for Type Culture Collection with a collection number of CCTCC KF 2008462; Pseudomonas syringae was purchased from the China General Microbiological Culture Collection with a collection number of CGMCC1.3214.

[0035] Example 1: Preparation of Tebuconazole

[0036] Add 60 g of tebuconazole epoxide, 20.7 g of 1,2,4-triazole, 2.7 g of CH3ONa, 8.4 g of KOH and 180 g of n-butanol into a reaction vessel, heat to 100 ° C and stir for 11 hours. After the reaction is completed, the reaction solution is distilled under reduced pressure to recover the solvent, the residue is extracted with toluene, washed with water, and the obtained organic phase is cooled, filtered and dried to obtain tebuconazole.

[0037] The tebuconazole prepared in this embodiment and the CAS107534-96-3 standard sample were measured under the same gas chromatography conditions. The retention time of the main peak of the chromatographic product in this embodiment was consistent with the main peak retention time of tebuconazole in the standard sample. It can be proved that the product prepared in this embodiment is tebuconazole. The yield of tebuconazole prepared in this embodiment is 95.7%, and the purity detected by liquid chromatography is 98.9%.

[0038] Example 2: Preparation of an antibacterial composition containing tebuconazole

[0039] 1. Raw material composition (by mass): 9.375 parts of tebuconazole, 0.625 parts of wolfsbane, 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, 5 parts of ethylene glycol, and 78 parts of water.

[0040] 2. Preparation Steps

[0041] (1) adding tebuconazole, wolfberry toner, sodium lauryl sulfate, dodecylbenzenesulfonic acid, n-octanol, xanthan gum, benzoic acid, and ethylene glycol to deionized water in sequence, performing ultrasonic emulsification for 30 minutes, and mixing uniformly to obtain a mixture;

[0042] (2) The mixture was sand-milled for 3 hours and homogenized for 30 minutes to obtain a suspension which was the antibacterial composition.

[0043] In Example 2, the weight ratio of tebuconazole to wolfsbane is 15:1, and the mass fraction of tebuconazole and wolfsbane in the antibacterial composition is 10%.

[0044] Example 3: Preparation of an antibacterial composition containing tebuconazole

[0045] Raw material composition (by mass): 28.125 parts of tebuconazole, 1.875 parts of wolfsbane, 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, 5 parts of ethylene glycol, and 58 parts of water.

[0046] In Example 3, the weight ratio of tebuconazole to wolfberry is 15:1, and the mass fraction of tebuconazole and wolfberry in the antibacterial composition is 30%. The preparation steps are the same as those in Example 1.

[0047] Example 4: Preparation of an antibacterial composition containing tebuconazole

[0048] Raw material composition (by mass): 46.875 parts of tebuconazole, 3.125 parts of wolfsbane, 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, 5 parts of ethylene glycol, and 38 parts of water.

[0049] In Example 4, the weight ratio of tebuconazole to wolfberry is 15:1, and the mass fraction of tebuconazole and wolfberry in the antibacterial composition is 50%. The preparation steps are the same as those in Example 1.

[0050] Example 5: Preparation of an antibacterial composition containing tebuconazole

[0051] Raw material composition (by mass): 30 parts of tebuconazole, 3 parts of wolfberry toxin, 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, 5 parts of ethylene glycol, and 55 parts of water.

[0052] In Example 5, the weight ratio of tebuconazole to wolfberry is 10:1, and the mass fraction of tebuconazole and wolfberry in the antibacterial composition is 33%. The preparation steps are the same as those in Example 1.

[0053] Example 6: Preparation of an antibacterial composition containing tebuconazole

[0054] Raw material composition (by mass): 20 parts of tebuconazole, 1 part of wolfsbane, 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, 5 parts of ethylene glycol, and 67 parts of water.

[0055] In Example 6, the weight ratio of tebuconazole to wolfberry is 20:1, and the mass fraction of tebuconazole and wolfberry in the antibacterial composition is 21%. The preparation steps are the same as those in Example 1.

[0056] Comparative Example 1: Preparation of Tebuconazole

[0057] Add 60 g of tebuconazole epoxide, 20.7 g of 1,2,4-triazole, 10.8 g of CH3ONa and 180 g of n-butanol into a reaction vessel, heat to 100 ° C and stir for 11 hours. After the reaction is completed, the reaction solution is distilled under reduced pressure to recover the solvent, the residue is extracted with toluene, washed with water, and the obtained organic phase is cooled, filtered and dried to obtain tebuconazole.

[0058] The tebuconazole prepared in this embodiment and the CAS107534-96-3 standard sample were measured under the same gas chromatography conditions. The retention time of the main peak of the chromatographic product in this embodiment was consistent with the main peak retention time of tebuconazole in the standard sample. It can be proved that the product prepared in this embodiment is tebuconazole. The yield of tebuconazole prepared in this embodiment is 78.2%, and the purity detected by liquid chromatography is 72.3%.

[0059] Comparative Example 2: Preparation of Tebuconazole

[0060] Add 60 g of tebuconazole epoxide, 20.7 g of 1,2,4-triazole, 11.2 g of KOH and 180 g of n-butanol into a reaction vessel, heat to 100 ° C and stir for 11 hours. After the reaction is completed, the reaction solution is distilled under reduced pressure to recover the solvent, the residue is extracted with toluene, washed with water, and the obtained organic phase is cooled, filtered and dried to obtain tebuconazole.

[0061] The tebuconazole prepared in this embodiment and the CAS107534-96-3 standard sample were measured under the same gas chromatography conditions. The retention time of the main peak of the chromatographic product in this embodiment was consistent with the main peak retention time of tebuconazole in the standard sample. It can be proved that the product prepared in this embodiment is tebuconazole. The yield of tebuconazole prepared in this embodiment is 88.1%, and the purity detected by liquid chromatography is 95.1%.

[0062] Comparative Example 3

[0063] The difference between Comparative Example 3 and Example 3 is that:

[0064] The wolfberry toxin in the raw material composition was omitted, and the rest was the same as in Example 3 to prepare a plant-derived antibacterial composition.

[0065] Comparative Example 4

[0066] The difference between Comparative Example 4 and Example 3 is that:

[0067] The botanical antibacterial composition was prepared by omitting tebuconazole from the raw material composition and keeping the other ingredients the same as in Example 3.

[0068] Test Example 1: Indoor toxicity determination

[0069] The antibacterial compositions of Examples 2-6 and Comparative Examples 3-4 were tested with reference to step 1.3 of indoor toxicity determination in the literature "Indoor toxicity and field disease prevention effects of 5 fungicides against peanut white rot fungus" (Fu Jing. China Plant Protection Guide, 2022).

[0070] The tested bacteria were Bipolaris sorokiniana, Fusarium graminearum, Gaeumannomyces graminis and Pseudomonas syringae.

[0071] The mycelium growth rate method was used to determine the antibacterial effect of the antibacterial composition of Examples 2-6 and Comparative Examples 3-4 on pathogenic bacteria. The antibacterial composition of Examples 2-6 and Comparative Examples 3-4 was prepared into a liquid with an active ingredient of 10 mg / L with sterile water, and 10 mL of the liquid was injected into a PDA medium (50 mL) that was sterilized, melted and cooled to 55°C. The liquid and the medium were fully mixed and poured into a culture dish with a diameter of 9 cm. After solidification, a drug-containing plate was formed, and the treatment with 10 mL of sterile water was used as a control. Each treatment was repeated 3 times. After the PDA plate was left to cool, a bacterial cake with a diameter of 1 cm was taken and placed in the center of the plate, and cultured in a constant temperature box at 28°C for 3 days. After the blank control plate was full of mycelium, the colony diameter of each treatment was measured by the cross method, and the antibacterial rate (R) of each agent treatment was calculated.

[0072] The calculation formula of the antibacterial rate is as follows:

[0073] R=(D0-D) / (D0-1)×100%

[0074] Where: R is the inhibition rate, D0 is the colony diameter of the control group (mm), and D is the colony diameter of the treatment group (mm).

[0075] 2. Test results:

[0076] Table 1 Antibacterial rate of the antibacterial composition of Examples 2-6 and Comparative Examples 3-4

[0077] Group Helminthosporium spp. Fusarium graminearum Graminoides Pseudomonas syringae Example 2 88.6% 95.6% 96.3% 88.2% Example 3 89.4% 97.2% 97.3% 89.2% Example 4 92.6% 98.8% 98.5% 91.3% Example 5 83.2% 93.4% 94.7% 87.6% Example 6 82.3% 95.3% 95.9% 85.7% Comparative Example 3 42.3% 78.2% 32.8% 52.3% Comparative Example 4 15.3% 14.5% 19.7% 21.5%

[0078] As can be seen from Table 1, the present invention compounds tebuconazole and wolf toxin, and as the mass fraction of tebuconazole and wolf toxin in the antibacterial composition increases, the antibacterial rate of wheat root rot flat umbilical worm spores, graminearum fusarium, graminearum capsule, and Pseudomonas syringae is gradually improved; wherein when the mass fraction of tebuconazole and wolf toxin in the antibacterial composition is 10%, the antibacterial rate of wheat root rot flat umbilical worm spores, graminearum fusarium, graminearum capsule, and Pseudomonas syringae is above 88%, which can prevent wheat root rot, wheat scab, wheat total rot or kiwi canker. Compared with Example 3, the active ingredient in the antibacterial composition of Comparative Example 3 is only tebuconazole, and the active ingredient in the antibacterial composition of Comparative Example 4 is only wolf toxin. The sum of the effects of the antibacterial rates of the two alone on the five strains is lower than the antibacterial rate of the antibacterial composition obtained by compounding the two on the five pathogens. The present invention compounds tebuconazole and wolf toxin, which has a synergistic effect in sterilization.

[0079] Test Example 2: Field Test

[0080] 1. Test methods

[0081] The experiment was carried out according to step 2 in the document "Research on Pesticide Reduction Technology for Control of Spring Wheat Root Rot and Wheat Field Weeds in Heilongjiang Province" (Guo Bocheng. Heilongjiang Bayi Agricultural University, 2021).

[0082] The test site is Zhao Xiaomiao Village, Zhanglou Town, Chengwu County, Heze City, Shandong Province, a plot where wheat root rot has been severely affected over the years. The wheat variety is Jimai No. 22. The experimental wheat was sown on October 6, 2022. The test was divided into 6 groups. The test fields that were treated with the antibacterial composition of Examples 2-4 were Groups 1-3; the test fields that were treated with the antibacterial composition of Comparative Examples 3-4 were Groups 4-5; and the blank control group Group 6 was not treated with seeds. Each treatment group was repeated 3 times, with a total of 18 plots, and the planting area of ​​each plot was 50m 2 . Conventional field management methods were adopted.

[0083] The test agent is a 2000-fold dilution of the antibacterial composition of Examples 2-4 and Comparative Examples 3-4. The wheat seeds and the test agent are fully stirred at a mass ratio of 5:1 until the seeds are evenly colored, and sowed after natural shade drying. When the wheat is in the 4-leaf stage, 4 sampling points are selected in a "Z" shape, and all seedlings with a row length of 1m are taken at each point to investigate the incidence of wheat root rot, record the total number of investigated plants and the number of diseased plants, and calculate the diseased plant rate and control effect.

[0084] If any of the following symptoms are met, the plant is infected with wheat root rot:

[0085] (1) There are no lesions on the stem base and the main and fibrous roots;

[0086] (2) There are a small number of lesions on the stem base and taproot, and the area of ​​lesions accounts for less than one-quarter of the total area of ​​the stem and root;

[0087] (3) There are many lesions on the stem base and taproot, and the area of ​​lesions accounts for one-fourth and one-half of the total area of ​​the stem and root;

[0088] (4) There are many lesions on the stem base and main root, and the lesion area accounts for one-half and three-quarters of the total area of ​​the stem and root;

[0089] (5) The lesions are continuous at the stem base and on the taproot, but the root system is not dead;

[0090] (6) Root necrosis, with the aerial parts of the plant wilting and approaching death or dying;

[0091] Calculation method of drug efficacy:

[0092] Disease rate (%) = (number of diseased plants / total number of plants) × 100

[0093] Control effect (%) = (1-number of diseased plants in treatment group / number of diseased plants in control group) × 100

[0094] 2. Test results

[0095] Table 2 Control of wheat root rot by different treatments

[0096]

[0097]

[0098] As shown in Table 2, the antibacterial composition of the present invention has an excellent control effect on wheat root rot in the field test, with a control effect of more than 80% and a diseased plant rate of less than 5%.

[0099] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. An antibacterial composition containing tebuconazole, characterized in that: The active ingredients of the antibacterial composition are tebuconazole and wolfberry, and the mass ratio of tebuconazole to wolfberry is 15:1; The tebuconazole is prepared by the following method: Tebuconazole epoxide and 1,2,4-triazole are used as reaction bases, CH3ONa and KOH are used as catalysts, and n-butanol is used as an organic solvent. The reaction is carried out at a temperature of 95-105° C. for 11-12 hours to purify and obtain tebuconazole; The molar ratio of tebuconazole epoxide, 1,2,4-triazole, CH3ONa and KOH is 5:6:1:3; The mass ratio of the tebuconazole epoxide to n-butanol is 1:3; The purification method comprises the following steps: after the reaction is completed, the reaction liquid is subjected to reduced pressure distillation to recover n-butanol, the residue is extracted with toluene, washed with water, and the obtained organic phase is cooled, filtered, and dried to obtain tebuconazole.

2. The antibacterial composition according to claim 1, characterized in that The tebuconazole and wolfberry toxin account for 10% to 50% of the mass of the antibacterial composition.

3. The antibacterial composition according to claim 1, characterized in that The antibacterial composition also includes an auxiliary agent accounting for 10% to 15% of the mass of the antibacterial composition, and the auxiliary agent is compounded from the following raw materials in parts by mass: 3 parts of sodium lauryl sulfate, 3 parts of dodecylbenzenesulfonic acid, 0.2 parts of n-octanol, 0.5 parts of xanthan gum, 0.3 parts of benzoic acid, and 5 parts of ethylene glycol.

4. The effect of the antibacterial composition according to any one of claims 1 to 3 in preventing and controlling crop diseases, characterized in that: The crop diseases are wheat root rot, wheat fusarium head blight, wheat take-all disease or kiwi fruit canker.

Citation Information

Patent Citations

  • Compound bactericide capable of preventing and treating wheat takeail

    CN101491250A

  • Biological bactericide-new neochamaejasmin B water dispersible granule and preparation method thereof

    CN103858877A

  • Compound bactericide for preventing and treating wheat scab

    CN104106580A

  • Sterilization composite containing ipconazole and tebuconazole and application thereof

    CN106070236A

  • Novel technology for synthesizing bactericide tebuconazole without solvent

    CN106588791A